Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 2007;116:1386-1395
Published online before print August 27, 2007, doi: 10.1161/CIRCULATIONAHA.106.653782
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
116/12/1386    most recent
CIRCULATIONAHA.106.653782v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Loukogeorgakis, S. P.
Right arrow Articles by MacAllister, R. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Loukogeorgakis, S. P.
Right arrow Articles by MacAllister, R. J.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Related Collections
Right arrow Ischemic biology - basic studies
Right arrow Endothelium/vascular type/nitric oxide
Right arrowRelated Article

(Circulation. 2007;116:1386-1395.)
© 2007 American Heart Association, Inc.


Molecular Cardiology

Transient Limb Ischemia Induces Remote Preconditioning and Remote Postconditioning in Humans by a KATP Channel–Dependent Mechanism

Stavros P. Loukogeorgakis, MBBS, BSc, PhD; Rupert Williams, MBBS, BSc; Anna T. Panagiotidou, MBBS, BSc; Shyamsunder K. Kolvekar, MBBS, MS, MCh, FRCS, FRCSTh; Ann Donald, AVS; Tim J. Cole, BA, BPhil, MA, PhD, ScD; Derek M. Yellon, PhD, DSc, Hon FRCP; John E. Deanfield, BA, BChir, MB, FRCP; Raymond J. MacAllister, MA, MD, FRCP

From the Vascular Physiology Unit, Institute of Child Health (S.P.L., R.W., A.T.P., A.D., J.E.D.), MRC Centre of Epidemiology for Child Health, Institute of Child Health (T.J.C.), Hatter Cardiovascular Institute and Centre for Cardiology (D.M.Y.), and Centre for Clinical Pharmacology and Therapeutics (S.P.L.), University College London; and Department of Cardiothoracic Surgery, UCL Hospitals NHS Foundation Trust (S.K.K.), London, United Kingdom.

Correspondence to Dr S.P. Loukogeorgakis, Vascular Physiology Unit, Institute of Child Health, University College London, 34 Great Ormond St, London, WC1N 3JE, UK. E-mail s.loukogeorgakis{at}ich.ucl.ac.uk

Received August 15, 2006; accepted July 5, 2007.

Background— Transient limb ischemia administered before a prolonged ischemic insult has systemic protective effects against ischemia-reperfusion (IR) injury (remote ischemic preconditioning [RIPC]). It has been demonstrated that protection from IR can be achieved by brief periods of ischemia applied at a remote site during an injurious ischemic event (remote postconditioning [RPostC]). Using an in vivo model of endothelial IR injury, we sought to determine whether RPostC occurred in humans and whether it shared mechanistic similarities with RIPC.

Methods and Results— Endothelial function was assessed by flow-mediated dilation before and after IR (20 minutes of arm ischemia followed by reperfusion). RIPC was induced by conditioning cycles of 5 minutes of ischemia and reperfusion on the contralateral arm or leg before IR. For RPostC induction, conditioning cycles were administered during the ischemic phase of IR. Oral glibenclamide was used to determine the dependence of RIPC and RPostC on KATP channels. IR caused a significant reduction in flow-mediated dilation in healthy volunteers (baseline, 9.3±1.2% versus post-IR, 3.3±0.7%; P<0.0001) and patients with atherosclerosis (baseline, 5.5±0.6% versus post-IR, 2.3±0.5%; P<0.01). This reduction was prevented by RIPC (post-IR+RIPC: healthy volunteers, 7.2±0.5% [P<0.0001 versus post-IR]; patients, 4.5±0.3% [P<0.01 versus post-IR]) and RPostC (post-IR+RPostC: 8.0±0.5%; P<0.0001 versus post-IR). The protective effects of RIPC and RPostC were blocked by glibenclamide.

Conclusions— This study demonstrates for the first time in humans that RPostC can be induced by transient limb ischemia and is as effective as RIPC in preventing endothelial IR injury. RIPC and RPostC share mechanistic similarities, with protection being dependent on KATP channel activation. These results suggest that remote conditioning stimuli could be protective in patients with acute ischemia about to undergo therapeutic reperfusion.


 

CLINICAL PERSPECTIVE


Related Article:

Issue Highlights
Circulation 2007 116: 1337. [Extract] [Full Text]



This article has been cited by other articles:


Home page
CirculationHome page
A. Prasad, G. W. Stone, D. R. Holmes, and B. Gersh
Reperfusion Injury, Microvascular Dysfunction, and Cardioprotection: The "Dark Side" of Reperfusion
Circulation, November 24, 2009; 120(21): 2105 - 2112.
[Full Text] [PDF]


Home page
J CARDIOVASC PHARMACOL THERHome page
H. L. Lujan and S. E. DiCarlo
Partial Hindlimb Occlusion Reduced the Susceptibility to Sustained Ventricular Tachycardia in Conscious Rats
Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2009; 14(3): 199 - 206.
[Abstract] [PDF]


Home page
ANGIOLOGYHome page
S. P. Hoole, P. M. Heck, P. A. White, S. N. Khan, M. O'Sullivan, S. C. Clarke, and D. P. Dutka
Remote Ischemic Preconditioning Stimulus Does Not Reduce Microvascular Resistance or Improve Myocardial Blood Flow in Patients Undergoing Elective Percutaneous Coronary Intervention
Angiology, August 1, 2009; 60(4): 403 - 411.
[Abstract] [PDF]


Home page
Eur J Heart FailHome page
S. P. Hoole, S. N. Khan, P. A. White, P. M. Heck, R. K. Kharbanda, C. G. Densem, S. C. Clarke, L. M. Shapiro, P. M. Schofield, M. O'Sullivan, et al.
Remote ischaemic pre-conditioning does not attenuate ischaemic left ventricular dysfunction in humans
Eur J Heart Fail, May 1, 2009; 11(5): 497 - 505.
[Abstract] [Full Text] [PDF]


Home page
Eur. J. Cardiothorac. Surg.Home page
G. Valen
Extracardiac approaches to protecting the heart
Eur. J. Cardiothorac. Surg., April 1, 2009; 35(4): 651 - 657.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. A. Kloner
Clinical Application of Remote Ischemic Preconditioning
Circulation, February 17, 2009; 119(6): 776 - 778.
[Full Text] [PDF]


Home page
CirculationHome page
S. P. Hoole, P. M. Heck, L. Sharples, S. N. Khan, R. Duehmke, C. G. Densem, S. C. Clarke, L. M. Shapiro, P. M. Schofield, M. O'Sullivan, et al.
Cardiac Remote Ischemic Preconditioning in Coronary Stenting (CRISP Stent) Study: A Prospective, Randomized Control Trial
Circulation, February 17, 2009; 119(6): 820 - 827.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
D. J. Hausenloy and D. M. Yellon
Remote ischaemic preconditioning: underlying mechanisms and clinical application
Cardiovasc Res, August 1, 2008; 79(3): 377 - 386.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
J. M. Downey and M. V. Cohen
Bypassing Big Pharma
Circulation, September 18, 2007; 116(12): 1344 - 1345.
[Full Text] [PDF]